Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06254768 · ClinicalTrials.gov registry record · NA
Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
A NA study of Pediatric Obesity, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06254768: Recruiting NA study of Pediatric Obesity, sponsored by University of California, Los Angeles.
NCT06254768 is a NA study of Pediatric Obesity that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06254768, a NA study of Pediatric Obesity, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
Primary Outcome
Investigator will measure this outcome using recruitment rate achieved each month for the duration of the study period as the number of participants screened per month over the number of participants consented.
Conditions Studied
Interventions
- DEVICE Continuous glucose monitor
Study Locations (1)
California
- Pediatric Endocrinology Division, University of California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-17 |
| Est. Completion | 2024-06 |
| Phase | NA |
What NCT06254768 shows while recruiting
NCT06254768 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Pediatric Obesity appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitor is the first listed.
NCT06254768 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06254768 about?
NCT06254768 is a clinical study titled "Use of Continuous Glucose Monitors in Children and Adolescents With Obesity". To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
What is the current status of trial NCT06254768?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-17. Estimated completion is 2024-06.
What conditions does trial NCT06254768 study?
This clinical trial studies the following conditions: Pediatric Obesity.
What interventions are being tested in trial NCT06254768?
The interventions under investigation include: Continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT06254768?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06254768 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06254768's enrollment target sits among peer trials
30 40th of 45 higher than 4 of 45 other Pediatric Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
iAmHealthy Clinical Practice Guideline (CPG)
RECRUITING · NA
-
Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)
RECRUITING · NA
-
Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health
RECRUITING · NA
-
Growing Healthy Children and Families in Rural Arkansas
RECRUITING · NA
-
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI